期刊文献+

肝细胞癌合并胆管癌的临床分型以及手术方式选择对疾病预后的影响 被引量:4

Clinical Classification of Hepatocellular Carcinoma with Bile Duct Cancer and Effect of Surgical Choice on Prognosis
下载PDF
导出
摘要 目的探讨肝细胞癌合并胆管癌的临床特征分型及手术治疗方式选择对远期效果的影响。方法回顾性分析100例肝细胞癌合并胆管癌患者的就诊资料、肿瘤临床分型及手术方式、生存资料,手术方式有胆管切开取癌栓、肝癌切除并胆管癌切除、胆管支架置入引流等,分析不同手术方式对远期预后的影响。结果 100例确诊并进行根治手术治疗的患者有92例,其中肝细胞癌切除并胆管切口取癌栓的有38例,肝细胞癌切除并胆管癌切除的有48例,胆管支架植入引流的有6例,术后围手术期死亡的患者有9例,25例出现围手术并发症,术后1年、2年、3年的生存率分别为63.0%、25.0%、19.6%,生存期平均为(20.6±10.6)个月。通过单因素分析结果显示肝细胞癌合并胆管癌生存期与临床分型及手术方式选择有关。多因素分析结果显示手术方式的选择为影响生存期的独立因素。结论手术方式的选择是影响肝细胞癌合并胆管癌治疗效果的重要因素。若能早期发现病灶并选择合理的手术方式进行根治,对于延长患者生存期具有重要的意义。 Objective To investigate the clinical characteristics of hepatocellular carcinoma with cholangiocarcinoma and the effect of surgical treatment on long-term outcome. Methods Retrospective analysis of treatment data, clinical classifica- tion of tumors and surgical methods, survival data of 100 cases of hepatocellular carcinoma patients with cholangiocarcinoma were conducted, surgical treatment included surgical removal of bile duct tumor thrombectomy, hepatectomy and bile duct resection, bil- iary stenting drainage,etc. ,the impact of different surgical methods on long-term prognosis were analyzed. Results Of the 100 patients,92 cases were diagnosed and underwent radical surgery,there were 38 cases received surgical removal of bile duct tumor thrombectomy,48 cases received hepatectomy and bile duct resection, 6 cases received biliary stenting drainage. Perioperative death after surgery were 9 cases, and postoperative perioperative complications 25 cases. !-, 2- and 3-year survival rates were 63.0% ,25.0% ,19.6% ,and the average survival time was (20.6 + 10.6) months. Univariate analysis showed that survival of hepatocellular carcinoma with cholangiocarcinoma was associated with clinical classification and surgical choice. Multivariate anal- ysis showed that the choice of surgical methods was risk factor affecting the survival of patients. Conclusion The choice of surgi- cal methods is an important factor affecting the efficacy of hepatocellular carcinoma with cholangiocarcinoma. Early detection of le- sions and selection of reasonable surgical approach have significance in prolong survival of patients.
作者 陈建武
出处 《实用癌症杂志》 2017年第6期950-952,955,共4页 The Practical Journal of Cancer
关键词 胆管癌 肝细胞癌 手术方式 远期预后 临床分型 Cholangiocarcinoma Hepatocellular carcinoma Surgical method Long-term prognosis Clinical classification
  • 相关文献

参考文献3

二级参考文献20

  • 1Jia Fan,Zhi Quan Wu,Zhao You Tang,Jian Zhou,Shuang Jian Qiu,Zeng Chen Ma,Xin Da Zhou,Sheng Long Ye Liver Cancer Institute, Zhongshan Hospital, Fudan University Medical Center (Former Shanghai University), 136 Yixueyuan Road, Shanghai 200032, China.Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein[J].World Journal of Gastroenterology,2001,7(1):28-32. 被引量:80
  • 2Bao-GangPeng Li-JianLiang Shao-QiangLi FanZhou Yun-PengHua Shi-MinLuo.Surgical treatment of hepatocellular carcinoma with bile duct tumor thrombi[J].World Journal of Gastroenterology,2005,11(25):3966-3969. 被引量:31
  • 3Satoh S, Ikai I, Honda G, et al. Clinicopathologic evaluation of hepatocellular carcinoma with bile duct thrombi[J]. Surgery, 2000, 128(5): 779-783.
  • 4Shao W, Sui C, Liu Z, et al. Surgical outcome of hepatocellular carcinoma patients with biliary tumor thrombi[J]. World J Surg Oncol, 2011, 9: 2.
  • 5Ikenaga N, Chijiiwa K, Otani K, et al. Clinicopathologic characteristics of hepatocellular carcinoma with bile duct invasion[J]. J Gastrointest Surg, 2009, 13(3): 492-497.
  • 6Ebara C, Yamazaki S, Moriguchi M, et al. Complete remission by transarterial infusion with cisplatin for recurrent bile duct tumor thrombus of hepatocellular carcinoma: report of a case[J]. World J Surg Oncol, 2013, 11: 78.
  • 7Shiomi M, Kamiya J, Nagino M, et al. Hepatocellular carcinoma with biliary tumor thrombi: aggressive operative approach after appropriate preoperative management[J]. Surgery, 2001, 129(6): 692-698.
  • 8Xiangji L, Weifeng T, Bin Y, et al. Surgery of hepatocellular carcinoma complicated with cancer thrombi in bile duct: efficacy for criteria for different therapy modalities[J]. Langenbecks Arch Surg, 2009, 394(6): 1033-1039.
  • 9Frank GA, Danilova NV, Andreeva IuIu, et al. WHO classification of tumors of the breast, 2012[J]. Arkh Patol, 2013, 75(2):53-63.
  • 10Yu XH, Xu LB, Liu C, et al. Clinicopathological characteristics of 20 cases of hepatocellular carcinoma with bile duct tumor thrombi[J]. Dig Dis Sci, 2011, 56(1): 252-259.

共引文献31

同被引文献37

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部